MOHW provides real-time confirmation service

for drug reimbursement progress

Promoting a pilot project in parallel with approval, reimbursement, and drug price for treatments with proven efficacy

Ministry of Health and Welfare 2023 Regulatory Innovation Plan, "Legalization of public late-night pharmacies"

When the government requests pharmaceutical companies to expand drug reimbursement standards, the government plans to use the information system to provide administrative services to check the progress of evaluation tasks at each stage.

 

Drugs with clear efficacy for survival-threatening diseases will strengthen patient accessibility by implementing a pilot project that simultaneously proceeds with permission from the Ministry of Food and Drug Safety, benefits evaluation by the Health Insurance Review and Assessment Service, and drug price negotiations with the National Health Insurance Corporation.

 

It also announced a plan to legalize public late-night pharmacies that provide pharmacist services to provide counseling for patients with mild symptoms and guarantee access to medicines.

 

On the 9th, the Ministry of Health and Welfare announced a plan to promote health and welfare regulatory reform in 2023.

 

This year, the Ministry of Health and Welfare will promote regulatory improvement in seven key areas, focusing on the regulatory innovation plan for the new health industry.

 

They are innovative medical devices, innovative and essential medicines, digital healthcare, advanced regenerative medicine and advanced biopharmaceuticals, genetic testing, BMI, and infrastructure.

 

In addition, we will continue to discover regulatory improvement tasks such as rapid registration of new drugs.

 

In the health and welfare sector, regulations are improved to allow new industries to enter the market by supporting innovation in the private sector, as population aging and increased demand for health care are expected.

 

Although leasing was prohibited after the sale of land to companies in the high-tech medical complex, various forms of occupancy opportunities were provided, such as allowing leasing only to resident companies in need of leasing, such as conducting joint research with a common goal.

 

We plan to revitalize the complex and improve space utilization.

 

When a pharmaceutical company requests an expansion of reimbursement standards for pharmaceuticals, the process of reviewing reimbursement standards is made transparent and predictability is increased by enabling the information system to check the progress of each evaluation task.

 

When evaluating drugs that are life-threatening and have sufficient improvement effects, a policy to promptly list new drugs is also implemented.

 

A pilot project will be conducted to strengthen patient accessibility by concurrently proceeding with permission from the Ministry of Food and Drug Safety, benefits evaluation by the Health Insurance Review and Assessment Service, and drug price negotiations with the National Health Insurance Corporation.

 

By legalizing public late-night pharmacies that provide counseling for patients with mild symptoms that occur at night and provide pharmacist services to ensure access to medicines, the public health blind spot is eliminated by providing medication counseling and drug use guidance to patients with mild symptoms during night time.

 

Despite changes in the environment of the pharmaceutical industry, the innovative pharmaceutical company certification system maintains its original form when introduced (2012).

 

Minister of Health and Welfare Cho Kyu-hong said, "In accordance with the strong regulatory innovation direction of the Yoon Seok-yeol government, we will continue to create results of regulatory innovation in the health and welfare sector to revitalize new industries and resolve difficulties and public inconvenience while putting top priority on the lives and safety of the people." revealed